Capital M

Vaccine Science: Two centuries of continuous research, improvements, and achievements

November 20, 2020 Maryland Tech Council Season 2 Episode 14
Capital M
Vaccine Science: Two centuries of continuous research, improvements, and achievements
Chapters
Capital M
Vaccine Science: Two centuries of continuous research, improvements, and achievements
Nov 20, 2020 Season 2 Episode 14
Maryland Tech Council

Dr. Leonard Friedland, Vice President and Director of Scientific Affairs and Public Health for GSK Vaccines joined Maryland Tech Council CEO, Martin Rosendale for this ZoomCast to discuss vaccine development, new technologies, and the two centuries of continuous research, improvements and achievements in the field.

Watch the ZoomCast here: https://youtu.be/XttK3FsEpPc 

Show Notes

Dr. Leonard Friedland, Vice President and Director of Scientific Affairs and Public Health for GSK Vaccines joined Maryland Tech Council CEO, Martin Rosendale for this ZoomCast to discuss vaccine development, new technologies, and the two centuries of continuous research, improvements and achievements in the field.

Watch the ZoomCast here: https://youtu.be/XttK3FsEpPc